Market Research Logo

The Worldwide Market for In Vitro Diagnostic Tests: 12th Edition

The Worldwide Market for In Vitro Diagnostic Tests: 12th Edition

What is the Size of the 2019 IVD Market?

How fast will the market grow?

What companies stand to gain?

Kalorama has answered these questions for readers for two decades. Now in its 12th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry.

The market for IVD currently stands at $69.2 billion dollars. It is poised for growth over the next five years, improved growth from the last edition of Kalorama’s report. There are hundreds of companies competing in the market in some form, and scores of large multi-test players.

Kalorama’s 2,000-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market. It is a global report, a comprehensive report and a reliable report that has been industry standard for two decades.

  • 2000-Page Report Based on Vendor Reporting, Interviews, Vendor Activities
  • Authored by Veteran IVD Analysts with Industry Knowledge
  • 12 Detailed Market Chapters with 2019 Market Estimate
  • Relevant Segmentation for Test Business Planners, Investors, New Entrants and Other Market Watchers
  • Where is IVD Heading? – Market Segment Projections to 2024
  • What’s Behind the Growth and Declines? – Market Numbers and Analysis
  • Regional Breakouts Including Country IVD Markets
  • Sections on China, Europe, Japan and The United States IVD Markets
  • Macro Analysis of Major Trends
  • Superior Company Profiles of Top Tier Companies and Hundreds of Smaller Concerns
  • Used by Major IVD Firms for Business Planning
  • Coverage of Trends and Market Estimates for Essential IVD Segments: Clinical Chemistry, Point-of-Care, Molecular, Infectious Disease, Histology and More.
In vitro diagnostic testing costs little to the healthcare system and contributes much to clinical practice. For some time this has been stated as educated conjecture; a recent study of U.S and German physicians offers proof. The study found that 66% of clinical decisions made were based on a diagnostic test, while the costs of those tests were just 2.3% of healthcare expenditure (Rohr U., Binder C, PLoS One. 2016). When the cost-effectiveness of in vitro diagnostic testing is then considered along with beneficial effects on treatment outcomes, therapy choices, and hospital management, there should be little surprise about the amount of interest in IVDs and the amount of activity in the market for them.

The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2024 for defined segments of the IVD market and various sub-segments, including:
  • Molecular Assays: Infectious Disease [HIV, Hepatitis, Respiratory, Others] Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal
  • Clinical Chemistry and “Core Lab” Markets: General Chemistries, Blood Gases, Urinalysis, Immunos run on Workstations
  • Point-of-Care Testing (POC): Professional and Self-Testing, Fertility, Colon Cancer, HbA1c POC, Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OT
  • Glucose Testing: Meters, Professional Testing, Continuous Glucose
  • Substance Abuse Testing (Employment Screening, Criminal Justice, Critical Care – Traditional POC)
  • Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases – DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
  • Blood Banking (Typing, Immunoassay Screen, NAT Blood Testing)
  • Histology and Cytology: Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV
  • Immunoassay Testing: Infectious Disease, Cardiac Markers, Tumor Markers, Autoimmune, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Total; w/o HbA1c
  • Hematology
  • Cardiac Markers, Tumor Markers, Diabetes/hbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs
  • Coagulation Tests
  • Direct-to-Consumer Testing
For each of the listed in vitro diagnostics market segments, 2019 in vitro diagnostics market size, 2024 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers’ product innovations. The market data is put into a context with real-world industry and medical practice trends. The Worldwide Market for In Vitro Diagnostic Tests has been called “The Bible of the IVD Industry” by customers, which include top IVD firms. Using Kalorama Information’s The Worldwide Market for In vitro Diagnostic (IVD) Tests, 12th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.

The IVD Market Opportunity by Country

The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 12th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included.

IVD Market Opportunity by Country is provided for the following countries: China, Philippines, Brazil, Israel, Malaysia, India, Mexico, Indonesia, Chile, Poland, Saudi Arabia, South Korea, Romania, Colombia, United Arab Emirates, Argentina, Hungary, Vietnam, Iraq, Peru, Japan, France, Turkey, Egypt, Singapore, Luxembourg, Croatia, Jordan, U.S., Germany, United Kingdom, Canada, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Denmark, Ireland, Finland, Iran, Thailand, Venezuela, Italy, Australia, Portugal, Greece, Czech Republic, South Africa, Norway, Bulgaria, Slovakia, Slovenia.

The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2019.

Who’s In The Market? Who’s Winning?

The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies.
  • Abbott Diagnostics
  • Arkray
  • Becton, Dickinson and Company (BD)
  • Beckman Coulter, Inc. / Danaher
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A
  • Grifols S.A.
  • Hologic, Inc.
  • Instrumentation Laboratory (IL) / Werfen
  • Ortho Clinical Diagnostics (Ortho)
  • QIAGEN N.V.
  • Radiometer A/S / Danaher
  • Roche Diagnostics
  • Siemens Healthineers (Siemens)
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen
  • Agilent Technologies
  • BGI Genomics (formerly Beijing Genome Institute)
  • Bruker Corporation
  • Cepheid
  • Eiken Chemical Co., Ltd
  • Fujirebio Diagnostics, Inc.
  • Illumina
  • LabCorp, Laboratory Corporation of America
  • Leica Biosystems
  • Luminex Corporation
  • A. Menarini Diagnostics
  • Meridian Bioscience, Inc.
  • Mindray – Shenzhen Mindray Bio-medical Electronics Co., Ltd.
  • Nova Biomedical Corporation (Nova)
  • PerkinElmer, Inc. (PE)
  • Philips (Royal Philips)
  • Quest Diagnostics
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Ventana Medical Systems Inc. / Roche Tissue Diagnostics
  • Diagnostica Stago, S.A.S.
  • AB SCIEX Pte Ltd
  • EKF Diagnostics Holdings Plc
  • ELITech Group S.A.S.
  • ERBA Diagnostics, Inc.
  • MedTest DX
  • Microsaic Systems plc
  • Nova Biomedical
  • Scienion AG
  • Sekisui Diagnostics LLC
  • Shimadzu Scientific Instruments
  • Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
  • Tecan Group
  • Tosoh Bioscience
  • Trinity Biotech Plc
  • Biocartis
  • Biocept, Inc.
  • Biodesix
  • Cynvenio Biosystems (LungLife AI)
  • Epigenomics AG
  • Foundation Medicine, Inc.
  • Genomic Health (Exact Sciences)
  • Guardant Health, Inc.
  • Menarini-Silicon Biosystems
  • Myriad Genetics, Inc.
  • Natera
  • NeoGenomics
  • Dexcom Inc.
  • Gentag Inc.
  • LifeScan Inc.
  • Medtronic plc
  • Nemaura Medical Inc.
  • CellaVision AB
  • Horiba Medical
  • Medica Corporation
  • Onca Xt Ltd
  • West Medica
  • Advanced Cell Diagnostics (ACD)
  • Amoy Diagnostics Co. Ltd.
  • Applied Spectral Imaging Inc. (ASI)
  • BioGenex Laboratories, Inc.
  • BioView Ltd.
  • Circulomics Inc.
  • Dako A/S
  • Definiens
  • HTG Molecular Diagnostics
  • Kapa Biosystems Inc.
  • Leica Biosystems
  • MilliporeSigma (formerly EMD Millipore)
  • Biohit Oyj (Biohit Healthcare)
  • Biomerica Inc.
  • Bio-Techne Corporation
  • Corgenix Medical Corporation
  • Critical Diagnostics
  • Eurobio Scientific
  • EUROIMMUN AG
  • HOB Biotech
  • Immunodiagnostic Systems (IDS)
  • INOVA Diagnostics, Inc.
  • Cerner Corp.
  • Dell Technologies Inc.
  • Desktop Genetics Ltd.
  • Accelerate Diagnostics, Inc.
  • Advanced Biological Laboratories, S.A. (ABL)
  • altona Diagnostics
  • ArcDia International Oy Ltd.
  • BioFire Diagnostics, LLC. (acquired by bioMérieux)
  • Bruker BioSciences Corporation
  • COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
  • Curetis
  • Fast Track Diagnostics (acquired by Siemens Healthineers)
  • Focus Diagnostics, Inc.
  • Genetic Analysis AS
  • Greiner Bio-One International GmbH
  • Hain Lifescience GmbH
  • Mast Group
  • Mobidiag Ltd.
  • Nanosphere, Inc. (Luminex)
  • OpGen, Inc.
  • PositiveID Corporation
  • Q-linea AB
  • Seegene, Inc.
  • Asuragen Inc.
  • AutoGenomics Inc.
  • Enzo Biochem Inc.
  • Exosome Diagnostics, Inc.
  • Fluidigm Corporation
  • GenMark Diagnostics, Inc
  • Genome Diagnostics BV (GenDx)
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies Ltd
  • Pacific Biosciences of California, Inc. (PacBio)
  • QuanDx Inc
  • RainDance Technologies, Inc.
  • Rubicon Genomics, Inc.
  • Takara Bio Inc.
  • Trovagene, Inc.
  • Vela Diagnostics
  • WaferGen Bio-systems, Inc.
  • Abaxis, Inc.
  • Abingdon Health Ltd.
  • Atlas Genetics Ltd. (Binx Health)
  • Biomeme, Inc.
  • Chembio Diagnostic Systems, Inc.
  • DNA Electronics Ltd (DNAe)
  • Entopsis
  • FABPulous B.V.
  • Fio Corporation
  • Genedrive plc (formerly Epistem Holdings)
  • PTS Diagnostics
  • QuantuMDx Group, Ltd.
  • Rheonix, Inc.
  • Samsung Healthcare
  • Veredus Laboratories Pte Ltd
  • and others …


  • Executive Summary
    • Table The Worldwide IVD Market, 2019-2024 ($millions)
    • Scope and Methodology
      • Table Exchange Rate Fluctuations, 2014 2018
    • Finding What You Are Looking For in the 12th Edition
      • Table Finding What You Are Looking For in the 12th Edition
    • Size and Growth of the Market
      • Table Global In Vitro Diagnostic Sales by Product Market, 2019-2024 ($ million)
      • Table Regional Distribution of IVD Market, 2019
    • IVD Market Highlights
    • Competitive Picture in IVD
    • What to Watch
      • China and Top Emerging Nations Markets
      • Next-Generation Sequencing and IVD
      • Direct-to-Consumer
      • Gene Editing
      • Liquid Biopsy
      • Information Technology and AI
      • New Venues – Urgent & Retail Care,” Microhospitals”
  • Introduction
    • IVD Landscape
    • Report Design
    • The Challenge of PAMA
    • Market Analysis of IVD Market Segments
      • Table Global In Vitro Diagnostic Sales by Product Market, 2019-2024 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry)
    • Top Suppliers and Niche Players
      • Introduction
      • Overview of the Top Tier Companies
        • Table Revenues of Selected Top IVD Companies, 2014-2018 ($ million, estimated)
      • Overview of Selected Second Tier Companies
        • Table Revenues of Selected Niche Players, 2014-2018 ($ million, estimated)
    • IVD Companies Mergers & Acquisitions
      • Table Selected IVD Mergers and Acquisitions late 2018 to mid-2019
    • Market Expansion Initiatives
      • Table Selected Market Expansion Initiatives, 2018 & H1 2019
    • Distribution Agreements
      • Table Selected Diagnostics Industry Distribution Agreements, 2016, 2017, 2018, 2019
    • Licenses and Collaboration Agreements
      • Table Selected IVD Partnerships/Collaborations/Licensing Agreements, 2016, 2017, 2018, 2019
    • Test Services
      • Table Selected Test Services, Sales 2013-2018 ($ millions, estimated where applicable)
      • Table Global Lab Market Segmentation, 2018 ($ billions) (Hospital Labs, Independent Labs, Physician Office Labs)
      • Table Revenues for a Selection of U.S.-based Reference Labs, 2013-2018 ($ million, estimated)
    • Historical IVD Market vs Today
      • In the Beginning to Now
        • Table Share of IVD Market by Segment, Percentage, 2000 and 2019 Compared (Clinical Chemistry, Hematology, Coagulation, Immunoassays, Microbiology (ID/AST), POC Diabetes, POC - Other, Histology/Cytology, Molecular, Blood Banking [imm & typing], Others)
      • Future
    • Point of View
  • The Global Picture for In Vitro Diagnostic Markets
    • Background
      • Simultaneous Threats: Chronic and Acute
      • Expected World IVD Market Developments
    • Global Population and Aging
      • Table Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
      • Workforce Reduction
        • Table Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World)
      • Addressing the Aging Trend
    • Shifting Disease Burdens
      • Table Changing DALY ranking of Disease Threats (disability-adjusted life year) Worldwide (HIV/AIDS, Malaria, Lung Cancer, TB, Neonatal Preterm Birth, Asthma, Heart Disease, Depression, Stroke, Cerebral Hemorrhage, Low Back Pain, Alzheimer's, COPD)
      • Increase in Chronic Diseases
    • Emerging and Emerged Markets
      • Table Available Market Data, 2018 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia)
      • Emerging Nations and Health Insurance
    • Size and Forecast for the Global IVD Market
      • Table Global In Vitro Diagnostic Market; Major Country/Region Markets, 2019 and 2024 ($ millions) (United States, EU 15/W. Europe, Japan, China, Canada, India, Eastern Europe, Brazil, Colombia, Mexico, Saudi Arabia, Turkey, UAE, Malaysia, Russia, South Africa, South Korea, Australia, ROW)
      • Regional Reporting Differences with the 11th Edition
    • The IVD Market in the United States
      • Table United States IVD Market by Segment, 2019 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Clinical Sequencing, Nucleic Acid Assays, Coagulation, Histology, Hematology, Blood Grouping, Others)
      • PAMA and Reimbursement Changes
      • LDT Oversight Update
      • Rare Disease Testing
      • Personalized Medicine and NGS
    • IVD Market in Europe: Continued Recovery
      • Table Europe: Growth in Healthcare Expenditure by Country, Projections 2018-2025 (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom)
      • Europe Industry Actions
        • Table Western European IVD Market by Country, 2019 ($ millions, estimated) (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland/Norway, UK)
      • EU Regulation
        • Table IVD Market Per Capita, Europe, 2018 Estimates (Switzerland, Germany, Netherlands, Sweden, France, Slovenia, United Kingdom, Italy, Spain, Slovakia, Greece, Croatia, Lithuania, Czech Republic, Hungary, Poland, Romania, Serbia, Bulgaria, Russia, Ukraine)
      • Personalized Medicine in Europe
      • Brexit
      • Austerity
    • Eastern Europe: Growth Region
      • Table Europe: Growth in Healthcare Expenditure by Country, Projections 2018-2025 (Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Slovak Republic, Slovenia)
      • Table Eastern European IVD Market by Country, 2019 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine)
      • Table Eastern Europe IVD Market by Country - Segment Distribution, 2019 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine)
    • Japan: Return to Growth
      • Table Japan IVD Market by Segment, 2019 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
    • China: Current IVD Market
      • Table China IVD Market by Segment, 2019 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
      • Table Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
      • Clinical Laboratory Tests in China
        • Table Number of Visits and Admissions to Hospital Institutions in China Annually, 2015 (General Hospitals, Specialized Hospitals, Chinese Medical Hospitals, Community Health Service Centers, Health Centers [Urban and Township], Village Clinics, Others)
      • Private Laboratories
      • Distribution in China
    • India: Population and Opportunity
      • Table India IVD Market by Segment, 2019 (%) (Clinical Chemistry, Hematology, Coagulation; Microbiology; POC Diabetes; POC Other; Immunoassay; Histology; Others)
      • Labs in India
    • Rest of Asia
      • Table Asia Pacific IVD Market by Country, 2019 ($ millions) (Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam)
    • Brazil
      • Disease Trends
        • Table Brazil IVD Market by Segment, 2019 (%)
    • Mexico
      • Table Mexico IVD Market by Segment, 2019 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
    • The Russian Federation
    • Canada
    • Emerging Markets
      • Saudi Arabia IVD Market
      • South Africa IVD Market
      • Turkey IVD Market
      • Colombia IVD Market
      • United Arab Emirates (UAE) IVD Market
      • South Korea IVD Market
      • Other Markets to Watch
    • IVD Market Opportunity by Country
      • Table IVD Market Opportunity by Country (2019 Market Rank, 2018 Market Rank, Country CAGR 2019-2024) (China, Philippines, Brazil, Israel, Malaysia, India, Mexico, Indonesia, Chile, Poland, Saudi Arabia, South Korea, Romania, Colombia, United Arab Emirates, Argentina, Hungary, Vietnam, Iraq, Peru, Japan, France, Turkey, Egypt, Singapore, Luxembourg, Croatia, Jordan, U.S., Germany, United Kingdom, Canada, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Denmark, Ireland, Finland, Iran, Thailand, Venezuela, Italy, Australia, Portugal, Greece, Czech Republic, South Africa, Norway, Bulgaria, Slovakia, Slovenia)
  • Company and Industry Trends
    • Introduction
      • Advanced Medicine Without Borders
      • China Market Information
      • IVD Company Initiatives in China
        • Table Selected IVD Initiatives in China
      • Clinical Genetic Test Advances
      • Direct to Consumer Genetic Test Services
      • Programs and Initiatives
        • Table Selected Genomic Test Innovations
      • Future Trends
    • Gene Editing
      • Table Selected Gene Editing / CRISPR Innovations
      • CRISPR as a Diagnostic Tool
      • Basic Research
      • Food Industry
      • Investor Interest
    • Microbiome
      • Table Selected Microbiome Test Innovations
    • Liquid Biopsy
      • Table Liquid Biopsy: Selected Liquid Biopsy Innovations
      • Quality Assurance
      • Product News
      • Market Cleared Products
      • For Research Use Only
      • Products in Development
      • Liquid Biopsy in Microbiology
      • The Future for Liquid Biopsy
    • Information Technology Advances and Artificial Intelligence
      • AI in Clinical Practice
        • Table Selected AI Market Cleared Tests
      • The Regulatory Pathway
      • Product Initiatives
        • Table Selected AI Product Initiatives in Development and Collaborations
      • IBM Watson Health
      • AI in Liquid Biopsy
        • Table Selected AI/Liquid Biopsy Initiatives
      • Future Trends
    • Exosome Sequencing
      • Table Selected Exosome Test Innovations
    • Biotin Interference in Immunoassay Detection Errors
      • Table Biotin-free Offerings Currently on the Market
    • Traumatic Brain Injury and IVD
    • Blockchain
    • Substance Abuse
      • Opioid Epidemic
      • Biomarkers and Substance Abuse
      • Clinical Laboratory Testing for Drugs of Abuse
        • Table Global Drug Abuse Statistics
      • Urine
      • Blood
      • Oral
      • Hair
        • Table Selected Opioid FDA Approvals, 2015-2019
    • Micro-hospital Opportunities
    • Climate Change and Infectious Disease
    • Kickback Schemes
    • Early Sepsis Detection
  • Point-of-Care Tests
    • Overview and Trends
    • Professional POC
      • Table Professional POC Test Sales by Category, Worldwide 2019 -2024 ($million) (Glucose, Critical Care POC, Fertility, Infectious Diseases, Cardiac Markers, Cholesterol, Coagulation, HbA1c POC, Hematology, Fecal Occult Blood, Drugs of Abuse, Others)
      • Table Selected Profession POC Test Innovations
    • OTC Self Testing
      • Table POC Self-Test Sales by Category, Worldwide, 2019-2024 ($million) (Glucose, Self; Glucose, Continuous; Pregnancy; Coagulation; Fecal Occult Blood; Drugs of Abuse; H. pylori; HIV; Cholesterol; Urinalysis; Other [TSH, Allergy, Autoimmune, etc])
    • Pregnancy/Fertility Tests
      • Table POC Pregnancy and Fertility Test Market Distribution by End User, 2019 (%) (OTC, PRO)
      • Table Pregnancy/Fertility POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
    • Colon Cancer Screening
      • Table Colon Cancer POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
    • Lipid Testing
      • Table Lipid POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
    • POC Infectious Disease Testing
      • Table Innovations in Molecular POC Infectious Disease Diagnostics
      • Products
      • HIV and Hepatitis Testing and Monitoring
      • Tuberculosis
      • Tropical and Neglected Diseases
      • Respiratory Diseases
      • Sepsis and Nosocomial Disease
      • Sexual Health
      • Lyme Disease
      • Market Size and Growth
        • Table Infectious Disease POC Test Demand by Type, 2019 (Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OTC, Others)
        • Table Infectious Disease POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
    • Diabetes Testing - Blood Glucose Monitoring
      • Glucose Testing in Tight Economics
        • Table Glucose POC Test Sales Distribution by Global Region, 2019 (United States, Europe, Japan, RoW)
        • Table POC Glucose Testing Market Growth by Category, 2019-2024 CAGR (%) (Glucose OTC; Glucose Professional; Glucose, continuous; HbA1c POC)
      • IT to Aid Diabetes Management
        • Table Selected Apps and Glucose Management IT
      • Diabetes Market Analysis
        • Table Global Diabetes Sales by Test Category, 2019-2024 (Glucose, OTC; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; HbA1c, Lab) ($ millions)
        • Table POC Test Revenues of Selected IVD Glucose Companies, 2019 ($ million, estimated)
      • Blood Glucose Self-Testing
        • Table Selected Glucose Self-Test Meter Innovations
      • Noninvasive Testing Devices
        • Table Selected Noninvasive Glucose Monitoring Devices
      • Continuous Self Testing en Route to the Artificial Pancreas
        • Table Selected Continuous Blood Glucose System Developments
      • Blood Glucose Testing by Professionals
        • Table Selected Innovations in Hospital-based Glucose Monitoring
      • Diabetes Testing Glycated Hemoglobin
        • Table Global HbA1c Test Sales Market and Distribution by Setting, 2019-2024 ($ millions) (HbA1c POC, HbA1c Lab)
        • Table Selected POC HbA1c Devices
      • Genes and Other Markers of Diabetes
        • Table Selected POC Diabetes Monitoring Tests
    • Drugs of Abuse Testing
      • Table POC Drugs of Abuse Test Sales Distribution by Setting, 2019 (Employment Screening, Criminal Justice, Critical Care - Traditional POC)
      • Products
        • Table Drugs of Abuse Tests on the Market
    • The Major POC Test Players
      • Table POC Test Revenues of Selected IVD Companies (excluding glucose), 2018-2019 ($ million, estimated)
  • The Core Lab
    • Core Lab Overview and Trends
      • Table Workstation Sales, 2019-2024 (General Chemistries, Immunoassays on workstations; $ millions)
      • Table Workstation Sales (General Chemistries, Immunos on Workstations) of the Top Five Manufacturers, 2018-2019 ($ millions, estimated)
      • Table Selected New Analytes for the Core Lab, 2016-2019
    • Connectivity
    • Overview of Chemistry Tests
      • Lab Automation
      • Service Plans
    • Market Analysis
      • Table Global Clinical Chemistry Sales by Test Category, 2019-2024 ($millions) (General Chemistries, Blood Gases, Urinalysis)
      • Table Global Clinical Chemistry Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
      • Table Major Clinical Chemistry Companies
      • Table Selected Clinical Chemistry Innovations
      • Rapid Response Systems
        • Table Major Whole Blood Chemistry Analyzers
      • Critical Care Analysis
        • Table Blood Gas, Electrolyte and Critical Care Instrument Market by End User, 2019 and 2024 (Labbased, POC-based)
        • Table Blood Gas, Electrolyte, and Critical Care Market Leaders, 2019 (percent distribution of total sales)
      • User Apps
        • Table Selected Apps, Critical Care and Urinalysis IT Innovations
      • Urinalysis
        • Table UA Market by End User, 2019 and 2024 (Lab-based, POC-based)
        • Table Urinalysis Systems Market Leaders, 2019 (percent distribution of total sales)
        • Table Selected Urinalysis Innovations
    • Sleep Apnea Testing: Core Lab Solution?
    • The Commercial Outlook for Chemistry Tests
  • Immunoassays
    • Overview and Trends
      • Immunoassay Technology Continues to Evolve
        • Table Selected Immunoassay Technologies 2019
      • Mass Spectrometry
        • Table Selected Innovation in Mass Spectrometry for Routine Analyses
      • Immunoassays in the Core Lab
        • Table Workstation (General Chemistries, Immunos on Workstations) Sales Growth, CAGR 2019-2024
        • Table Selected Immunoassay Innovations on Core Lab Instruments
      • Radioimmunoassays
    • Market Analysis
      • Leading Suppliers and Growth Potential
        • Table Global Lab-based Immunoassay (excluding infectious disease and blood screening) Sales, by Analyte Type, 2019-2024 ($millions) (Cardiac Markers, Tumor Markers, Autoimmune, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Total; w/o HbA1c)
        • Table Global Immunoassay (excluding infectious disease and blood screening) Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
        • Table Selected Immunoassay Quality Control Products
        • Table 2019 Revenue of Leading Immunoassay Vendors (in millions $), Estimated
    • Mature Assay Segment
      • Thyroid Function
      • Therapeutic Drug Monitoring
      • Anemia
      • Toxicology/DAU
      • Allergy
    • Maturing Immunoassays
      • Proteins
    • Growth Immunoassays
      • Vitamin D
        • Table Selected Vitamin D Immunoassays
      • Tumor Markers
        • Table Selected Tumor Marker Innovations
      • Cardiac Markers
        • Table Selected Cardiac Marker Innovations
      • Autoimmune
        • Table Selected Autoimmune Test Innovations
      • Rheumatoid Arthritis
        • Table Selected Arthritis Immunoassay Innovations
      • Gastrointestinal Disorders
        • Table Selected Inflammatory Bowel Disease Test Innovations
      • Transplant Management
        • Table Selected Immunoassays for Transplant Medicine
      • Women's Health
        • Table Selected Women's Health Innovations
      • Alzheime's Diease
        • Table Selected Innovations for Alzheimer's Disease
      • Sleep Apnea
      • Miscellaneous
        • Table Selected Immunoassay Innovations
      • Point-of-Care OTC and Professional Use
        • Table Global POC Immunoassay Sales Distribution by Region, 2019 (United States, Europe, Japan, RoW)
        • Table Global POC Immunoassay Test Sales by Test Category, 2019-2024 (millions $) (OTC/Self Tests: Pregnancy/Ovulation, Drugs of Abuse, HIV, H. pylori, Other, OTC/Self Total; Professional POC: Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other, Professional Total)
        • Table Selected Self-Test Immunoassay Innovations
      • Pregnancy Testing
      • Cardiovascular Diagnostics
      • Drugs of Abuse/Therapeutic Drug Monitoring
    • Innovating POC
      • Table Selected POC Test Innovations
      • Table Selected POC Immunoassay Test Platforms
    • The Commercial Outlook for Immunoassays
  • Molecular Assays
    • Overview
      • Table Common Next Generation Molecular Test Traits
    • Sample Preparation and Quality Control
      • Table Selected Molecular Test Sample Preparation and QC Innovations
    • Advanced Molecular Tests and Technologies
      • Exosome Sequencing
        • Table Selected Exosome Test Innovations
      • Liquid Biopsy
        • Table Selected Liquid Biopsy Innovations
      • Metabolomic Profiling
      • Information Technology for Test Value
        • Table Selected IT Innovations in Molecular Diagnostics
      • Forensic Studies An Emerging Opportunity
        • Table Selected Innovations in Forensic DNA Testing
      • Test Platforms
        • Table Key Molecular Technologies and Major Players
        • Table Selected Molecular Test Platform Innovations
    • Major Players
      • Table Molecular Test Revenues of Selected IVD Vendors, 2016-2019 (in millions $)
    • Market Analysis
      • Table Global Molecular Test Sales by Type 2019-2024 (in millions $) (Oncology, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
      • Oncology
        • Table Global Molecular Cancer Test Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
      • Pharmacodiagnostics
        • Table Global Pharmacodiagnostic Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
        • Table Selected Molecular Tumor Marker Test Innovations
      • Inherited Diseases and Thrombophilia SNPs
        • Table Most Frequently Requested Genetic Tests
        • Table Global Molecular Thrombophilia Assay Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
        • Table Selected Genomic Tests for Inherited Diseases
      • Psychiatric Disorders
      • Prenatal and Newborn Testing
        • Table Global Prenatal Test Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
        • Table Prenatal Services Provided
        • Table Selected Molecular Tests for Prenatal Analysis
      • Tissue Typing
        • Table Global Molecular HLA Testing Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
        • Table Selected HLA Typing Test Innovations
    • The Commercial Outlook for Molecular Tests
  • Hematology
    • Overview of Hematology and Trends
      • Digital Image Analysis
        • Table CellaVision Market Share Data by Hematology Vendor 2019
        • Table Selected Hematology Image Analysis Innovations, 2014-2019
      • Digital Evolution
      • Quality Control Measurement Programs
    • Laboratory-based Hematology Testing
      • Table Selected Hematology Innovations, 2014-2019
      • Table Global Laboratory-based Hematology Test and Instrument Market, 2019 and 2024 ($ millions)
      • Regional Laboratory-based Hematology Test and Instrument Market
        • Table Global Laboratory-based Hematology Test and Instrument Market, by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Decentralized Hematology Testing
      • Hemoglobin/Hematocrit at the POC
        • Table Selected POC Hemoglobin and Hematocrit Systems
        • Table Decentralized Hematology Test and Instrument Market, 2019 and 2024 ($ millions) (Instruments, lab-style; Handheld devices)
    • Market Analysis: Leading Suppliers
      • Table Top Hematology, including d-dimer, Company Revenues (laboratory and POC), 2019 ($ millions)
      • Table Global Hematology (Laboratory-based and POC) Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • The Commercial Outlook for Hematology Tests
  • Coagulation
    • Overview and Trends of Coagulation and Immunohematology Tests
    • Special Topics
      • Direct Oral Anticoagulants (DOACs)
      • D-dimer
        • Table Global D-dimer Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Market Analysis
      • Table Global Coagulation Sales by Segment, 2019-2024 ($millions) (PT/INR Labs, Molecular, Professional POC, Professional Self; D-dimer)
      • Table Global Coagulation Test and Instrument Market by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Lab-based Testing
      • Table Selected Lab-based Coagulation Innovations
      • Genetic Markers of Hypercoagulopathies
        • Table Global Molecular - Thrombophilia SNP Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
        • Table Selected Molecular Coagulation Test Innovations
    • Leading Suppliers: Laboratory Systems
      • Table Top Coagulation Company Revenues, Laboratory-based - 2019 ($ millions)
    • Decentralized Coagulation Testing Professional Use
      • Decentralized Coagulation Testing OTC
        • Table Selected POC Coagulation Test Innovations
      • Platelet Testing
        • Table Selected Platelet Activity Test Innovations
    • Leading Suppliers: POC Systems
      • Table Top Coagulation Company Revenues, POC - 2019 ($ millions)
    • The Commercial Market for Coagulation Tests
      • Table Major Anticoagulants Uses and Tests
  • Microbiology and Virology
    • Important Statistics
      • Table The Top Ten Leading Causes of Death
    • The Real Impact of Infections
      • Herpes and Alzheimer's Disease
      • Ebola and Cancer
      • HIV and Cancer
      • H pylori and Cancer
      • Bacteria and Parkinson's
    • Microbial Antibiotic Resistance - The Role of Clinical Tests
      • "Faster Identification: Where Are we?"
        • Table Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
    • Traditional Microbiology and Its Limits
    • The New Microbiology - Innovations
      • Liquid Based Microbiology and Automation Innovations
      • Post-Blood Culture Microbial ID
      • PCR and Other NAAT-Based Tests for Infectious Diseases
        • Table Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology
      • Microbiome-Related Microbiology Tests
        • Table Selected Microbiome-Based Tests
      • Next Generation Sequencing-Based Microbiology Approaches
        • Table Selected Companies Applying DNA/RNA Sequencing to Microbiology
      • Syndromic Testing
    • New Infectious Disease Threats
      • Table Selected Companies Marketing Products Addressing Emerging Infectious Disease Threats
      • Tickborne Diseases (TBDs)
      • Zika
      • Chagas
      • Dengue
      • Ebola
      • Chikungunya
      • Next Threats?
    • Microbiology Firms Acquisitions and Collaborations
    • Market Analysis
      • Table Global Microbiology Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
    • Market Analysis - Traditional Microbiology ID/AST
      • Table Global Microbiology ID/AST Market, 2019-2024 (in millions USD) (ID/AST Auto, ID/AST Panels, Blood Culture, Chromogenic Media, Rapid Microbiology; ID/AST Supplies)
      • Table Global ID/AST Testing Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
      • Traditional ID/AST
        • Table Global ID/AST Testing, Distribution by Systems, 2019 (%) (Panel, Auto)
      • Blood Culture
        • Table Selected Advanced Techniques in Positive Blood Culture
      • Chromogenic Media
      • Rapid Tests Performed on Colonies from Culture Media
      • Supplies
    • Market Analysis - Microbiology Immunoassays
      • Improvements in Microbiology Immunoassays
        • Table Selected Infectious Disease Immunoassay Innovations
        • Table Global Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market by Pathogen, 2019 (in $ millions) (Hepatitis, HIV, STDs, TORCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Lyme disease, Other)
        • Table Global Clinical Chemistry Laboratory-Based Microbiology/Infectious Disease Immunoassay Market Distribution (by %) by Region, 2019 (North America, Europe, Asia Pacific, RoW)
      • Hepatitis Testing
      • Sepsis
      • HIV Immunoassay Testing
        • Table Selected HIV Assays
      • Sexually Transmitted Diseases (STDs)
      • TORCH
      • Lyme Disease
      • Rapid Immunoassay Tests
        • Table Global Rapid Immunoassay Testing Market, Sales Distribution by Pathogen, 2019 (%) (Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OTC, Others)
    • Market Analysis - Molecular Microbiology
      • Table Global Molecular Microbiology Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
      • Table Global Molecular Microbiology Market, by Pathogen/Disease Indication, 2019-2024 (in $ millions) (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria/TB, Others; Blood Bank Screening)
      • Molecular Respiratory Infection Testing
        • Table Selected Molecular Point of Care Innovations in Microbiology
      • Molecular Testing for Sexually Transmitted Diseases
      • Molecular Hepatitis Testing
      • Molecular HIV Testing
        • Table Innovations in Molecular POC Diagnostics for HIV
      • Molecular Tests for Hospital-Acquired Infections (HAIs)
        • Table Frequency of the Most Common Nosocomial Infections
      • Clostridium Difficile
      • MRSA
      • Molecular TB Testing
      • Limitations of Molecular Microbiology Testing
    • Mass Spectrometry
      • Table Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]
    • The Future Outlook for Microbiology
  • Blood Banking Services
    • Overview
      • Table History of Blood Testing
    • The Current Status of Global Blood Collection
      • Table Distribution of Blood Units Collected, 2011-2013 (United States, United Kingdom, India, Japan, China, Canada, ROW, World Total)
    • Global Blood Safety
      • Table Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV, Chagas, Malaria, HTLV I/II)
      • Table Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
      • Zika Virus
    • Blood and Component Collection
      • Table Blood Component Usage for Selected Conditions
      • Table Red Blood Cell and Platelet Use by Hospital Services (%)
    • Reevaluating Blood Transfusions
      • Table Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
    • Blood Typing and Grouping Market
      • Manual Blood Typing Methods
      • Automated Blood Typing and Screening Methods
      • Molecular Methods
      • Reducing Blood Typing Errors
        • Table Selected Blood Typing and Grouping Innovations
      • Size and Growth of Typing Markets
        • Table Global Blood Typing Market, 2019-2024 (Typing) (in $ millions)
      • Blood Typing Market by Geography
        • Table Global Blood Typing Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
    • Blood Testing Market
      • Table Selected Blood Testing Innovations
      • Preventing Bacterial Infections
      • Immunoassays
      • Nucleic Acid Testing (NAT)
      • Size and Growth of the Market
        • Table Global Blood Banking Diagnostics Market, 2019-2024 (Immunoassay Screen, NAT Screens) (in $ millions)
      • Blood Testing Market by Geography
        • Table Global Blood Testing Market by Geography, 2019 (%) (North America, Europe, Asia Pacific, RoW)
        • Table Global Blood Testing Market by Country, 2019 (%) (United States, Canada, Germany, United Kingdom, France, Japan, China, Latin America)
    • The Commercial Outlook for Blood Banking Testing
  • Histology and Cytology
    • Overview
    • Special Topics
      • Histology Automation
        • Table Selected Histology Lab Automation
        • Table Histology Information Technology Tools
      • Advanced Analysis Solutions
        • Table Selected Advanced Histology Techniques
      • HPV Goes Core Lab
        • Table Global HPV Test Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
        • Table Selected HPV Test Innovations
    • Market Analysis
      • Table Global Histology/Cytology Sales by Type, 2019-2024 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL; Digital Imaging, CTCs, Flow Cytometry)
      • Histology/Cytology
        • Table Global Histology/Cytology Sales Distribution by Region, 2019 (%) (North America, Europe, Asia Pacific, RoW)
        • Table Revenues of the Major Histology Companies, 2016-2019 ($ millions, estimated)
        • Table Selected Vendors of Traditional Histology Stains
      • Immunohistochemistry and In Situ Hybridization
        • Table Selected In Situ Hybridization-based Tests
        • Table Selected IHC Test Innovations
      • Pharmacodiagnostic Histology
        • Table Major Pharmacodiagnostic Markers
        • Table Selected Pharmacodiagnostic Histology Tests
      • Digital Imaging and Computational Pathology
        • Table Selected Digital Imaging Innovations
      • Circulating Tumor Cells
        • Table Selected Innovations in CTC Technology
      • Flow Cytometry
    • The Commercial Outlook for Histology and Cytology Tests
  • Company Profiles: The Top Tier
    • Abbott Diagnostics
      • Key Comment
      • Recent Revenue History
      • Alere Acquisition Update and Point of Care
      • Core Lab
      • Hematology
      • Blood Banking
      • Coagulation
      • Infectious Diseases - Molecular
      • Diabetes
      • HIV Point of Care
      • i-STAT Business
      • Companion Testing
      • Liquid Biopsy
    • Arkray
      • Key Comment
      • Dry Chemistry / Immunoassays
      • Urinalysis
      • Diabetes
      • Molecular
    • Becton, Dickinson and Company (BD)
      • Key Comment
      • Recent Revenue History
      • Cytology
      • Molecular Microbiology
      • Traditional Microbiology - ID/AST
      • Blood Culture
      • Hospital Acquired Infections
      • Connectivity
      • Blood Collection
      • Mass Spectrometry
      • Flow Cytometry
      • Licensing
    • Beckman Coulter, Inc. / Danaher
      • Key Comment
      • Recent Revenue History
      • Hematology
      • Hematology IT
      • Clinical Chemistry
      • Immunoassays
      • Coagulation
      • Microbiology
      • Urinalysis
      • Clinical Information Technology
      • Molecular Tissue Analysis
      • Flow Cytometry
      • A Fight for Brain Natriuretic Peptide (BNP) Assay Rights
      • Beckman Coulter Life Sciences
      • Collaborations
    • bioMérieux Inc.
      • Key Comment
      • Recent Revenue History
      • Traditional Microbiology
      • Blood Culture
      • Immunoassays
      • Mass Spectrometry
      • Data Analysis
      • BioFire Diagnostics Business
      • Food Testing
      • Expansion
    • Bio-Rad Laboratories, Inc.
      • Key Comment
      • Recent Revenue History
      • Company Highlights in 2017 and 2018
      • Quality Control
      • Blood Bank
      • Diabetes
      • Immunoassays
      • Autoimmune Testing
      • Liquid Biopsy
      • Microbiome
      • Droplet Digital PCR
      • Sequencing
    • Danaher Corporation
      • Key Comment
      • Recent Revenue History
      • For 2018 vs 2017, Danaher Reported
      • Acquisitions
    • DiaSorin S.p.A
      • Key Comment
      • Recent Revenue History
      • Development Plan
      • Expansion
      • Immunoassays
      • Zika Testing
      • Molecular
      • Molecular Oncology
    • Grifols S.A.
      • Key Comment
      • Recent Revenue History
      • Blood Transfusion Business
      • ABO Blood Typing
      • Molecular ABO Blood Typing
      • Immunoassays
      • Coagulation
      • Market Expansion
    • Hologic, Inc.
      • Key Comment
      • Recent Revenue History
      • Hologic Global Access Initiative
      • PANTHER Molecular System
      • HIV Testing
      • Sexually Transmitted Infections
      • Infectious Diseases
      • Panther Fusion
      • Cytology
    • Instrumentation Laboratory (IL) / Werfen
      • Key Comment
      • Recent Revenue History
      • 2018 Product Highlights
      • Expansion
      • Coagulation
      • Acute Care
      • Information Technology
    • Ortho Clinical Diagnostics (Ortho)
      • Key Comment
      • Recent Revenue History
      • Blood Bank
      • Core Lab / Immunoassays
      • Lab Automation
      • Connectivity
      • Expansion
    • QIAGEN N.V.
      • Key Comment
      • Recent Revenue History
      • Tuberculosis
      • Molecular Expansion
      • Precision Medicine / Companion Diagnostics
      • Molecular Microbiology
      • Prenatal Testing
      • Next Generation Sequencing
      • Sample Prep, Informatics
      • Digital PCR
      • Bioinformatics
      • Liquid Biopsy
      • Microbiome
      • Cervical Cancer
      • Transplant Medicine
      • Forensic
      • Expansion
    • Radiometer A/S / Danaher
      • Key Comment
      • Recent Revenue History
      • Critical Care
      • Immunoassays
      • HemoCue
      • Transcutaneous Monitoring
    • Roche Diagnostics
      • Key Comment
      • Recent Revenue History
      • For 2018 Compared to 2017
        • Table Selected Roche Diagnostics Product Advances in 2018
      • Hematology
      • Core Lab
      • Immunoassays
      • Global Access Program for HIV
      • Molecular Expansion
      • Core Molecular
      • Digital PCR
      • Diabetes Care
      • Coagulation
      • cobas Liat System - POC
      • HPV
      • Blood Bank
      • Transplant Medicine
      • Cancer Companion Testing
      • Prenatal
      • Liquid Biopsy
      • IT in Anatomical Pathology
      • Information Technology
      • NimbleGen Business
      • Consulting Program
    • Siemens Healthineers (Siemens)
      • Key Comment
      • Recent Revenue History
      • Core Lab
      • Lab Automation
      • Immunoassays
      • Hematology
      • Urinalysis
      • Molecular
      • Expansion to Support Molecular Diagnostics - Fast Track Diagnostics
      • Sequencing with Artificial Intelligence
      • Zika Virus Testing
      • Acute Care - POC
      • POC Connectivity
      • Business Expansion
    • Sysmex Corporation
      • Key Comment
      • Recent Revenue History
      • Hematology
      • Coagulation
      • Urinalysis
      • Immunoassays
      • Lab Information System
      • Information Technology
      • Flow Cytometry
      • Precision Medicine / Companion Test Diagnostics
      • Liquid Biopsy
      • Exosomes
      • Oncology
      • Sysmex Inostics
      • Forging New Markets
    • Thermo Fisher Scientific Inc.
      • Key Comment
      • Recent Revenue History
      • Immunoassays
      • Microbiology
      • Molecular Test Business
      • Next Generation Sequencing
      • qPCR
      • Gene Editing
      • Oncology Companion Diagnostics
      • Liquid Biopsy
      • Zika Virus
      • Transplant Medicine
      • Microbiome
      • Forensics
      • Mass Spectrometry
      • Collaborations
      • China
    • Werfen
      • Key Comment
      • Recent Revenue History
      • Instrumentation Laboratory
      • Inova Diagnostics
      • Biokit
  • Company Profiles: The Second Tier
    • Agilent Technologies
      • Key Comment
      • Recent Revenue History
      • Agilent in Genomics
      • Cytogenetic Analysis
      • Information Technology
      • Capillary Electrophoresis
      • Sequencing
      • CRISPR
      • Flow Cytometry
      • Dako / Pathology
    • BGI Genomics (formerly Beijing Genome Institute)
      • Key Comment
      • Recent Revenue History
      • MGI Tech Co., Limited, China
      • With Complete Genomics
      • Prenatal Testing
      • Test Services
      • Liquid Biopsy
      • Whole Genome Sequencing (WGS)
      • Collaborations
    • Bruker Corporation
      • Key Comment
      • Recent Revenue History
      • Acquisitions and Collaborations
      • Microbiology
      • Molecular PCR
    • Cepheid / Danaher
      • Key Comment
      • Recent Revenue History
      • GeneXpert Xpress Line
      • High Burden Expansion
      • India
      • Tuberculosis
      • Microbiology
      • POC Testing
      • Cancer
    • Eiken Chemical Co., Ltd
      • Key Comment
      • Recent Revenue History
      • Road Map Initiatives
      • Product News
    • Fujirebio Diagnostics, Inc.
      • Key Comment
      • Recent Revenue History
      • Molecular
    • Illumina
      • Key Comment
      • Recent Revenue History
      • Company Reported Highlights in 2018
      • Reported Highlights in 2016, 2017
      • Sequencing
      • Advancing in the Clinical Market
      • Sequencing Data Analysis
      • Sample Preparation
      • Microarrays
      • Project Firefly
      • Transplant Medicine
      • Liquid Biopsy
      • Forensic Medicine
      • Prenatal Testing Business
      • Collaborations
      • China
      • Investment
    • LabCorp, Laboratory Corporation of America
      • Key Comment
      • Recent Revenue History
      • LabCorp Buys Sequenom
      • Precision Medicine
      • Diagnostics Services
      • DTC Home Testing
      • Prenatal
      • Retail Services
      • Expansion
    • Leica Biosystems
      • Key Comment
      • Recent Revenue History
      • Digital Pathology
      • Stain Reagents
      • Lab Systems
      • Sample Handling
      • Circulating Tumor Cells (CTCs)
      • Artificial Intelligence
    • Luminex Corporation
      • Key Comment
      • Recent Revenue History
      • Assay Development
      • Verigene Business
      • PCR
      • Flow Cytometry
      • Business Expansion
    • A. Menarini Diagnostics
      • Key Comment
      • Menarini-Silicon Biosystems Inc. (Bologna, Italy)
    • Meridian Bioscience, Inc.
      • Key Comment
      • Recent Revenue History
      • Immunoassays
      • Molecular Tests
      • Building U.S. and International Partnerships
      • China Businesses
    • Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
      • Key Comment
      • Recent Revenue History
      • Core Lab
      • Hematology
    • Nova Biomedical Corporation (Nova)
      • Key Comment
      • Recent Revenue History
    • PerkinElmer, Inc. (PE)
      • Key Comment
      • Recent Revenue History
      • Diagnostics
      • Sequencing /Genomics
      • Liquid Biopsy
      • Histology
      • Prenatal Business
      • Lab Services
      • Mass Spectrometry
    • Philips (Royal Philips)
      • Key Comment
      • Histology
      • Cancer Genomics
      • Precision Medicine
      • Precision Medicine IT
      • Patient Monitoring
      • Point of Care
      • Wearable Self Monitor
    • Quest Diagnostics
      • Key Comment
      • Recent Revenue History
      • Reported Highlights
      • Diagnostic Services
      • Oncology
      • Infectious Diseases
      • Prenatal and Women's Health
      • Retail / Consumer Health
      • Expansion
    • Quidel Corporation
      • Key Comment
      • Recent Revenue History
      • Quidel Reported for 2018
      • The Alere Triage Business
      • Immunoassays
      • Rapid Immunoassays
      • The Solana Business
      • Molecular - Savanna
    • Randox Laboratories Ltd.
      • Key Comment
      • Clinical Chemistries
      • Controls
      • Evidence Series - Multistat Biochip Analyzers
      • Molecular
    • Ventana Medical Systems Inc. / Roche Tissue Diagnostics
      • Key Comment
      • Recent Revenue History
      • Immunohistochemistry - IHC
      • Cervical Cancer Screening
      • Companion Diagnostics
      • Quality Control
      • DISCOVERY Product Line
  • Company Profiles: Blood Bank Specialists
    • Bloodsource (Vitalant)
    • Cerus Corporation
    • Haemokinesis Pty Ltd
    • Immucor
    • MicroTyping Concepts
    • Quotient Limited
    • Reliance Life Sciences
  • Company Profiles: Coagulation Specialists
    • Diagnostica Stago, S.A.S.
    • Microvisk Technologies
    • DIAGON Kft. Hungary
  • Company Profiles: Core Lab and Other Companies
    • AB SCIEX Pte Ltd.
    • EKF Diagnostics Holdings Plc
    • ELITech Group S.A.S.
    • ERBA Diagnostics, Inc.
    • MedTest DX
    • Microsaic Systems plc
    • Nova Biomedical
    • Scienion AG
    • Sekisui Diagnostics LLC
    • Shimadzu Scientific Instruments
    • Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
    • Tecan Group
    • Tosoh Bioscience
    • Trinity Biotech Plc
  • Company Profiles: CTC & Liquid Biopsy Test Providers
    • Angle, plc
    • Biocartis
    • Biocept, Inc.
    • Biodesix
    • Cynvenio Biosystems (LungLife AI)
    • Epic Sciences
    • Epigenomics AG
    • Foundation Medicine, Inc.
    • Genomic Health (Exact Sciences)
    • Guardant Health, Inc.
    • Menarini-Silicon Biosystems
    • Myriad Genetics, Inc.
    • Natera
    • NeoGenomics
  • Diabetes Specialists
    • Animas Corporation
    • Ascensia Diabetes Care Holdings AG
    • Bigfoot Biomedical Inc.
    • Cellnovo Group SA
    • Debiotech SA
    • Dexcom Inc.
    • Gentag Inc.
    • Glooko Inc.
    • GlySure Limited
    • Glytec LLC
    • iHealth Labs Inc.
    • Insulet Corporation
    • Integrity Applications Inc.
    • LifeScan Inc.
    • Medtronic plc
    • Nemaura Medical Inc.
    • Nightscout Project
    • Sanofi
    • Trividia Health Inc.
    • Verily Life Sciences LLC
  • Company Profiles: Hematology (Cell Analysis) Specialists
    • CellaVision AB
    • Horiba Medical
    • Medica Corporation
    • Onca Xt Ltd
    • West Medica
  • Company Profiles: Histopathology Specialists
    • Advanced Cell Diagnostics (ACD)
    • Amoy Diagnostics Co. Ltd.
    • Applied Spectral Imaging Inc. (ASI)
    • BioGenex Laboratories, Inc.
    • BioView Ltd.
    • Circulomics Inc.
    • Dako A/S
    • Definiens
    • HTG Molecular Diagnostics
    • Kapa Biosystems Inc.
    • Leica Biosystems
    • MilliporeSigma (formerly EMD Millipore)
    • Omnyx LLC
    • Visiopharm
  • Company Profiles: Immunoassay Specialists
    • BG Medicine, Inc
    • Binding Site Group Ltd. (The)
    • Biohit Oyj (Biohit Healthcare)
    • Biomerica Inc.
    • Bio-Techne Corporation
    • Corgenix Medical Corporation
    • Critical Diagnostics
    • Eurobio Scientific
    • EUROIMMUN AG
    • HOB Biotech
    • Immunodiagnostic Systems (IDS)
    • INOVA Diagnostics, Inc.
    • Integrated Diagnostics (now Biodesix)
    • One Lambda, Inc
    • Orgentec Diagnostika
    • Protagen Diagnostics
    • Response Biomedical Corp.
    • Singulex, Inc.
    • Theradig
    • VolitionRx Limited
  • Information Technology Specialists in In Vitro Diagnostics
    • Advaita Corp.
    • Cerner Corp.
    • Dell Technologies Inc.
    • Desktop Genetics Ltd.
    • DNAnexus Inc.
    • Edico Genome (Illumina)
    • Euformatics Oy
    • Genalice
    • GenomOncology LLC
    • Google LLC
    • Human Longevity Inc.
    • Intel Corporation
    • International Business Machines Corp. (IBM)
    • N-of-One
    • PierianDx
    • Rennova Health, Inc.
    • SOPHiA GENETICS SA
    • Sunquest Information Systems Inc.
    • WuXi NextCODE
  • Company Profiles: Microbiology Specialists
    • Accelerate Diagnostics, Inc.
    • Advanced Biological Laboratories, S.A. (ABL)
    • altona Diagnostics
    • ArcDia International Oy Ltd.
    • BioFire Diagnostics, LLC. (acquired by bioMérieux)
    • Bruker BioSciences Corporation
    • COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
    • Curetis
    • Fast Track Diagnostics (acquired by Siemens Healthineers)
    • Focus Diagnostics, Inc.
    • Genetic Analysis AS
    • GeneWEAVE Biosciences, Inc.
    • Greiner Bio-One International GmbH
    • Hain Lifescience GmbH
    • Mast Group
    • Mobidiag Ltd.
    • Nanosphere, Inc. (Luminex)
    • OpGen, Inc.
    • PositiveID Corporation
    • Q-linea AB
    • Seegene, Inc.
      • Recent Revenue History
    • Specific Technologies
    • Synbiosis Ltd.
    • T2 Biosystems
  • Company Profiles: Molecular Test Specialists
    • Asuragen Inc.
    • AutoGenomics Inc.
    • Enzo Biochem Inc.
    • Exosome Diagnostics, Inc.
    • Fluidigm Corporation
    • GenMark Diagnostics, Inc
    • Genome Diagnostics BV (GenDx)
    • NanoString Technologies, Inc.
    • Oxford Nanopore Technologies Ltd
    • Pacific Biosciences of California, Inc. (PacBio)
    • QuanDx Inc
    • RainDance Technologies, Inc.
    • Rubicon Genomics, Inc.
    • Takara Bio Inc.
    • Trovagene, Inc.
    • Vela Diagnostics
    • WaferGen Bio-systems, Inc.
  • Company Profiles: Point of Care Test Specialists
    • Abaxis, Inc.
    • Abingdon Health Ltd.
    • Atlas Genetics Ltd. (Binx Health)
    • Biomeme, Inc.
    • Chembio Diagnostic Systems, Inc.
    • DNA Electronics Ltd (DNAe)
    • Entopsis
    • FABPulous B.V.
    • Fio Corporation
    • Genedrive plc (formerly Epistem Holdings)
    • Hema Diagnostic Systems (HDS; dba NuGenerex Diagnostics)
    • Immunostics, Inc.
    • InSilixa Inc.
    • Loop Medical (formerly QloudLab SA)
    • MedMira, Inc.
    • OraSure Technologies, Inc.
    • PTS Diagnostics
    • QuantuMDx Group, Ltd.
    • Rheonix, Inc.
    • Samsung Healthcare
    • Veredus Laboratories Pte Ltd
  • Company Profiles: Prenatal Test Service Providers
    • Affymetrix, Inc.
    • Berry Genomics Co. ltd.
    • CombiMatrix (Invitae)
    • CooperGenomics (Division of CooperSurgical)
    • Counsyl (Myriad Women’s Health)
    • GenePeeks, Inc.
    • Genetadi Biotech S.L.
    • Genoma Group
    • Innovations Exchange Pte Ltd (INEX) and iGene Diagnostics Pte Ltd
    • LifeCodexx AG
    • Oxford Gene Technology
    • Premaitha Health (Yourgene Health)
    • Ravgen
    • Reproductive Genetics Innovations
    • Sequenom, Inc.
  • Company Profiles: Quality Control & Sample Pretreatment Specialists
    • 10x Genomics
    • Agena Bioscience, Inc.
    • Biotype Diagnostic GmbH
    • DxTerity Diagnostics Inc.
    • Horizon Discovery Group plc
    • IncellDx
    • Oasis Diagnostics Corporation
    • PreAnalytiX GmbH
    • Precipio, Inc. (formerly Transgenomic)
    • Quanterix Corporation
    • SeraCare Life Sciences, Inc.
    • Streck Inc.
  • Test Service Providers
    • 23andMe
    • Agendia BV
    • Ambry Genetics
    • ARUP Laboratories
    • Assurex Health
    • The BioCollective
    • BioReference Laboratories
    • Biotheranostics
    • BluePrint Genetics Oy
    • Boston Heart Diagnostics
    • CareDx, Inc.
    • Cleveland HeartLab Inc.
    • Eurofins Genomics
    • Exact Sciences Corp.
    • Genomic Vision
    • Helomics Corporation
    • Mayo Medical Laboratories
    • MDxHealth SA
    • OPKO Diagnostics
    • Pathway Genomics Corporation
    • Sonic Healthcare
    • Veracyte, Inc.
    • Vermillion Inc.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report